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Summary 
The role of CD28-mediated  signals  in T  helper cell maturation is not fully understood.  We 
tested the requirement for costimulation through CD28 in several systems of CD4 + T  cell dif- 
ferentiation. In vivo priming of mice with genetic disruption of CD28 (CD28 -/-) yielded nor- 
mal levels of antigen-specific interferon ~/production but markedly diminished levels of inter- 
leukin 4  (IL-4) after in vitro restimulation.  In response to the pathogenic microbe, Leishmania 
major, C57BL6 CD28 -/- mice were fully capable of controlling infection and exhibited a nor- 
mal T  helper 1 response. BALB/c CD28 -/- mice unexpectedly exhibited normal susceptibility 
to L.  major. BALB/c CD28 -/- mice developed high levels oflL-4 mRNA and protein induc- 
tion in the draining lymph nodes. In addition, susceptibility of BALB/c CD28 -/- mice was re- 
versed by neutralization  of IL-4 in vivo. We also activated transgenic  CD28-bearing T  cells 
from the BALB and C57BL background in vitro in the presence of CTLA4Ig. BALB cells had 
greater IL-4-producing capacity than C57BL cells in the absence of costimulation. Diverse fac- 
tors including costimulatory signals,  genetic polymorphism, and the nature of the immunogen 
all influence T  helper phenotype commitment, but these results provide evidence that CD28 is 
not an absolute requirement for generating either Thl or Th2 responses. 
U 
'nder most circumstances, successful T  cell activation 
requires a signal delivered through the T  cell antigen 
receptor  and  a  second  signal  referred  to  as  costimulation 
(1).  T  cells  activated in vitro in the presence of CD28-B7 
blockade display characteristics of anergy (2),  and blockade 
in vivo has attenuated many T  cell-mediated immune re- 
sponses, including graft rejection  (3,  4)  and autoimnmnity 
(5-7). Analysis of CD28-deficient mice revealed relatively 
normal T  cell development, preserved cytolytic T  cell re- 
sponses, but impaired B  cell help (8). The role of costimu- 
lation  in  the  generation  and  maintenance  of antigen-spe- 
cific  CD4 +  T  helper  (Th)  subsets  remains  controversial. 
Data  supports  models  in  which  both  Thl  and  Th2  re- 
sponses require CD28-mediated signals  (2, 9-11), but some 
evidence suggests that only certain  Th subsets are depen- 
dent on costimulation (12-20).  Other findings suggest dis- 
crete stages of maturation selectively require  CD28-medi- 
ated costimulation  (12),  and some current models propose 
that specific B7 ligands mediate biased Th maturation (5, 6, 
21, 22). 
Daniel R. Brown and Jonathan M.  Green contributed equally to this 
work. 
In  murine  infection  with  Leishmania  major,  pathogen- 
specific CD4 + Th effectors mediate the polarized potential 
outcomes  of infection  (23).  Thl  responses  that  arise  in 
C57BL/6 mice result in self-limited heating disease through 
successful macrophage activation by T  cell-derived IFN-y. 
Th2  responses  that  arise  in  mice  from  the  BALB  back- 
ground  mediate  inexorable  susceptibility  characterized  by 
uncontrolled  parasite  dissemination.  The  unique  localiza- 
tion of the parasite to MHC class II-rich intracellular com- 
partments leads to a strong bias in CD4 +, class II-restricted 
imnmnization,  such  that  polarized  anti-leishmanial  Thl 
and Th2 phenotypes proceed normally, even in the genetic 
absence of MHC class I-restricted responses (24,  24a).  In- 
terventions that reduce the  efficiency of CD4 + T  cell re- 
sponses can  result  in  increased  susceptibility  to  infection. 
Transient  suppression  of T  cell  immunity,  however,  can 
also yield a default from a Th2 to Thl response with conse- 
quent healing in the BALB/c strain (23). 
To address the requirements of CD28-mediated costina- 
ulation in generating Thl  and Th2 subset development in 
vivo, we infected CD28-deficient mice from both C57BL/6 
and  BALB/c  backgrounds  with  L.  major.  We  also  tested 
antigen-specific cytokine responses to a nonpathogenic an- 
tigen,  keyhole limpet hemocyanin  (KLH).  IL-4 and,  to  a 
lesser extent,  IFN-y production are augmented by CD28- 
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production in vitro,  genetically driven polarization of Th 
responses  and  stereotyped  disease  phenotypes  were  ob- 
served in Leishmania-infected,  CD28-deficient mice. Trans- 
genic T  cells from the BALB and C57BL backgrounds had 
reduced IL-4 levels when primed in vitro in the presence 
of CTLA4Ig.  Addition of rlL-4  during priming restored 
IL-4 levels from BALB cells,  but not C57BL T  cells. To- 
gether, these results provide evidence that CD28 is not ab- 
solutely required for  generating a  Th2  response  in  vivo. 
Genetic background, the  replicating nature of the  micro- 
bial immunogen, and/or the strength of other second signal 
activities provided in vivo may overcome  the  need for  a 
component  of activation  formerly  deemed  indispensable 
for Th cell function. 
Materials and Methods 
CD28-d~cient Mice.  CD28 -/-  mice were  generated as  de- 
scribed (8). The animals used in these experiments were from the 
fifth  back-cross  to  C57BL/6  and fourth  or  fifth  back-cross  to 
BALB/c.  Heterozygote  and wild-type littermates  were  used  as 
controls for BALB/c experiments.  Commercial wild-type mice 
(Jackson Laboratories, Bar Harbor, ME) were used as controls for 
C57BL/6 experiments. Mice were housed in a specific pathogen- 
free environment. Genotypes were determined by flow cytome- 
try  using stains  for  commercially conjugated fluorescent  mAbs 
against  CD28  and CD4  (Caltag  Laboratories,  South  San  Fran- 
cisco, CA) and confirmation by PCR using two oligonucleotide 
pairs specifically spanning the genomic disruption of CD28 and 
the neomycin resistance marker.  All work was perfomaed  in ac- 
cordance with  University of Chicago guidelines for animal use 
and care. 
KLH Immunization.  BALB/c CD28 -/- and C57BL/6  CD28 -/ 
mice plus normal littermate controls were immunized in the hind 
footpads  and base  of the  tail with  100  txg KLH  (Calbiochem- 
Novabiochem Corp.,  San  Diego,  CA)  emulsified  in complete 
Freund's adjuvant (GIBCO Bt<L,  Gaithersburg,  MD).  8 d after 
immunization, draining lymph nodes were harvested  and single 
cell suspensions were prepared  in complete DME media (supple- 
mented with 10% FCS, 2-mM t-glutamine, I00 U/ml penicillin, 
100 txg/ml streptomycin, 50 ~M 2-ME, 10 m/Vl Hepes,  and 100 
~M nonessential amino acids). For the restimulation assay, 5  X 
10  s cells were plated in each well of a flat-bottom 96-well micro- 
titer plate  (Costar Corp., Cambridge, MA)  with either media or 
KLH at  100 ~g/ml. Supernatants for these and all other experi- 
ments were harvested at 48 h and analyzed for IL-4 and IFN-"/by 
ELISA  using commercial mAb pairs  (PharMingen, San  Diego, 
CA) according to the manufacturer's instructions. 
h!~'ction with L. major.  Infections were  performed  by  injec- 
tion of 5  ￿  10  ~ metacyclic  promastigotes  (WHOM/IR/-/173) 
into each hind footpad.  Lesion size was measured  weekly with a 
metric caliper. Select animals were treated with 5 mg n~Ab 11BI 1 
(rat  IgG1  antiumrine IL-4)  intraperitoneally on day  0.  Parasite 
cultures  were  quantitated by homogenization of tissue in fixed 
volumes of parasite  media.  Aliquots were  diluted serially across 
96-well plates and scored at 1 and 2 wk for parasite growth. Leish- 
mania-infected  mice were killed at 6-8 wk after infection and an- 
alyzed as individual animals. 
Single cell suspensions of popliteal lymph node cells were ex- 
amined for antigen-specific  cytokine production by restimulation 
in vitro and also for direct ex vivo IL-4 production by ELISPOT. 
For the restimulation assays, 0.5-1  ￿  10" lymph node cells per 
well were cultured in a 96-well round bottom microtiter plate in 
complete  media  with  and  without  soluble  Leishmania antigen 
(100 llg/ml). MHC class II was blocked using mAb M5/114 (rat 
IgG2b anti-A  b,d and -Ea,k), while mAb 10-2-16 served as an iso- 
type  control (mouse  IgG2b anti-Ak).  Supernatants  from the  re- 
stinmlation cultures were removed at 48 h and analyzed for IL-4 
and IFN-y production by ELISA. 
ELISPOTs were performed as previously  described  (25) using 
commercial mAb pairs (PharMingen). Briefly, plates were coated 
with purified antibody, 10  (' lymph node cells were plated in two- 
fold  serial dilutions and incubated at  37~  for  4  h.  IL-4 spots 
were  detected by sequential  addition of biotinylated secondary 
antibody,  streptavidin alkaline phosphatase  (Jackson  ImnmnoRe- 
search Laboratories Inc., West Grove,  PA), followed by develop- 
ment with  t  mg/ml 5-bromo-4-chloro-3-indolyl phosphate  in 
0.1  M  2-amino-2-methyl-l-propanol  (Sigma Chemical Co.,  St. 
Louis, MO) containing 0.6% agarose. 
Lymph node cells taken directly from  the  animal were  also 
placed  immediately in RNAzol (Biotecx  Laboratories,  Houston, 
TX)  and total  RNA  was  extracted  according to  the  manufac- 
turer's instructions, tLNA was reverse  transcribed  using random 
hexamer primers  (Pharmacia  Fine Chemicals,  Piscataway,  NJ). 
Semiquantitative PCR was performed as described  (26). Briefly, 
cDNA was amplified  in the presence  of a polycolnpetitor con- 
struct  that contains addition nmtations of the authentic cDNA. 
Resolved on agarose gels, the larger molecular weight bands pro- 
vide an internal standard  for  the  relative  amounts of the  lower 
molecular weight experimental cDNAs. Concentrations ofcDNAs 
are adjusted using the housekeeping gene HPRT before  assay of 
lymphokine gene transcription.  Results were verified by repeti- 
tion of both individual samples and whole experiments. 
hi vitro Priming qf Trami~enic T Cells.  Transgenic D011.10 mice 
recognizing a chicken ovalbumin-derived (OVA)  peptide in the 
context of GA  d were  generously provided by Dr.  l)ennis Loh 
(27).  Animals used  in these  experiments were  from  the  fourth 
back-cross  to  B10.D2  or  the  eighth  back-cross  to  BALB/c. 
Transgenic mice were identified by flow cytometry using stains 
for  comlnercially conjugated fluorescent  mAbs against V[38 and 
CD4 (Caltag). Primary cultures were performed in 24-well plates 
using 5  ￿  10  s splenocytes  from transgenic  mice stimulated  with 
100 ~g/ml of a trypric  digest of OVA protein (Sigma). Human 
CTLA4Ig (20 Ixg/ml; a generous gift from Gary Gray, Repligen 
Corp., Boston, MA)  was used to block B7-mediated costinmla- 
tion. After 6 d, cells were washed  extensively and counted. Sec- 
ondary  stimulations  were  replated  in  96-well  round-bottom 
plates in triplicate,  using 2  X  I0  s T  cells, 1.2  X  10  ~' irradiated 
wild-type splenocytes  (2,500 rads) as APCs,  and 100 Ixg/ml pep- 
tide. No cytokine or CTLA4Ig additions were used m secondary 
cultures.  Supernatants  were  harvested  at  48  h  and  assayed by 
ELISA. 
Results 
CD28-deficient Mice Produce Less Antigen-specific  IL-4 after 
In  Vivo Immunization with KLH.  To  determine how  sig- 
nals  delivered  specifically  through  CD28  affect  Th  cell 
maturation we  examined the  ability of CD28 -/-  mice to 
generate IFN-3,- and IL-4-producing cells after immuniza- 
tion.  CD28-deficient  mice  bred  onto  the  BALB/c  or 
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Impaired Th2 response after in vivo priming of CD28-defi- 
cient nfice. C57BL/6 and BALB/c wild-type (+/+) and CD28-deficient 
(-/-)  mice were immunized with KLH, as described in Materials and 
Methods. Draining lymph node cells were restimulated with KLH  in 
vitro, and supernatants  were assayed after 48 h for IL-4 and IFN-'y  by 
ELISA. Bars depict the mean values of duplicate wells with the standard 
deviation expressed as y-axis error bars. Cytokine levels in wells without 
antigen were below 10 U/ml. Results are representative of four separate 
experiments, 
C57BL/6  background  and  CD28-positive  controls  were 
immunized with  KLH.  In both genetic backgrounds, the 
absence of CD28 reproducibly resulted in a  10- to 20-fold 
decrease in IL-4 production upon antigen restimulation of 
draining lymph node cells compared to  their CD28-posi- 
tive controls (Fig. 1).  In contrast, the levels of IFN-y were 
similar in both wild-type and CD28-deficient mice of both 
strains.  These  results  suggested  that  Th2  responses  were 
more severely impaired than Thl  responses.  Of particular 
note, there was profound difference in IL-4 production be- 
tween BALB/c  and C57BL/6  backgrounds, with  at  least 
10-fold  greater  IL-4  levels  in  BALB/c  animals  when 
matched for CD28 expression. The genetic disparity led to 
levels of IL-4 production that  were  comparable between 
BALB/c CD28 -/- and wild-type C57BL/6 mice. 
CD28-deficient  C57BL/6  Mice  Control  Infection  with  L. 
major with Normal Th l-Type Responses.  To address the re- 
quirement for CD28-mediated signals in microbial immu- 
nity,  we  challenged CD28-deficient mice  with  L.  major. 
CD28 +/+  and CD28 -/  mice from the resistant C57BL/6 
background and  susceptible BALB/c  mice  were  infected 
with L.  major promastigotes in the hind footpad and moni- 
tored  for  their response to  intbction. C57BL/6  CD28 -/- 
mice and C57BL/6 wild-type mice both controlled infec- 
tion as assessed  by footpad lesion size (Fig. 2 A). Quantita- 
tive parasite cultures revealed equivalently low burdens for 
all C57BL/6 background animals that were approximately 
five orders of magnitude less in the feet and three orders of 
magnitude  less  in  the  spleens  than  susceptible  BALB/c 
mice. CD28-deficient mice also displayed normal delayed- 
type  hypersensitivity responses  to  Leishmania  antigens  in 
comparison to wild-type C57BL/6 mice (data not shown). 
Analysis of Th cytokine production in infected animals 
was  performed  by restimulating single-cell suspensions of 
popliteal lymph node cells with soluble Leishmania antigens 
in vitro. Compared to wild-type C57BL/6 mice, CD28 -/- 
mice had normal levels of antigen-specific IFN-y produc- 
tion and comparably low levels of antigen-specific IL-4 pro- 
duction (Fig. 2  B).  In addition, cytokine production could 
be  blocked with  anti-class II mAbs in culture  (Fig.  2  B), 
suggesting that conventional class II-restricted Th cells are 
the  source  of these  cytokines.  Analysis of cytokine tran- 
scripts taken directly ex vivo from lymph nodes of CD28 -/ 
also revealed fully mature Thl responses compared to con- 
trol-resistant  mice  (Fig.  2  C).  Furthermore,  C57BL/6 
CD28 -/- mice healed in an IFN-y-dependent fashion, as 
demonstrated by the ability of anti-IFN-y mAb treatment 
to  abrogate  resistance  in  both  the  CD28-deficient  and 
wild-type  controls  (data  not  shown).  We  conclude  that 
CD28-mediated costinmlation is not required for efficient 
Thl responses in vivo against this pathogen. 
Figure 2.  C57BL/6  CD28 /- mice control infection  with L. major. (A) Disease phenotype in response to infection  of BALB/c, C57BL/6 CD28  +/+, and 
C57BL/6 CD28  -/- mice is depicted as the mean lesion  size for each group with the standard deviations  as y-axis  error bars. (B) In vitro cytokine produc- 
tion from CD28-deficient  mice. Draining  lymph node cells were cultured with media alone (open bar), antigen  plus an isotype control mAh (black bar, Ag + 
ctrl Ab), or antigen plus anti-class  II blocking mAb (,tray bar, Ag + ca C II). Supernatants  were assayed for IL-4 and IFN-y production at 48 h by ELISA. 
Bars depict the mean of triplicate wells with the standard deviation  expressed as y-axis  error bars. Results are representative  of five experiments  using  a to- 
tal of 11 C57BL/6 CD28  -/  mice. (C') Senfiquantitative  competitive  PCR of draining  lymph node cells from representative  C57BL/6 CD28  +/+ (B6), sus- 
ceptible BALB/c (B/c), and two C57BL/6 CD28 /- mice. Amplification  was performed as described in Materials and Methods. Within each reaction, 
the upper band represents amplification  of competitor DNA, while the lower band represents amplification  of authentic cDNA, Differences  in the level 
ofmRNA between experimental  groups is standardized by the relative  intensi  W  compared to the internal standard. Input cDNA was equalized  by ampli- 
fication of HPRT. Results are representative  of three separate experiments. 
805  Brown et al. Figure 3.  BALB/c CD28 -/  nfice are susceptible to L. major. (A) Disease phenotype in response to infection  of C57BL/6, BALB/c C1328  +'-, and 
BALB/c CD28  /- nuce is depicted  as the mean lesion size for each group with standard deviations as },-axis error bars. (B) In vitro restimulation  ofcy- 
tokine production from BALB/c CD28-deficient (-/-)  and CD28-positive (+/+  and +/-)  mice. Draining popliteal lymph node cells were cultured 
w!th antigen and supematants assayed for IL-4 (black bar) and IFN-"/ (gray bar) production  at 48 h by ELISA. Bars depict the mean of triplicate wells from 
individual animals with standard deviation expressed as }*-axis  error bars. Results are representative of five experiments using 24 CD28  /- mice. For some 
experiments,  resistant C57BL background  controls were MHC H-2d--congenic B10.1)2 mice (sometimes designated only as BI0). (C') Ex vivo analysis of 
cytokine expression using semiquantitative  competitive PCR. cDNA from draining popliteal lymph nodes was amplified as in Fig. 2 C. Each lane repre- 
sents cDNA from individual animals. R.esults are representative  of three separate experiments.  (D) Ex vivo and in vitro comparison  of IL-4 production. 
ELISPOT assays were performed  on cells immediately  upon isolation or after 2 d of restimulation with antigen in vitro. The number of IL-4-producing 
cells/well is the fraction of IL-4-producing  cells nmltiplied by the number  of viable cells. The bars represent averages of two B10.D2  (1310), two BALB/c 
CD28 +''-, or five BALB/c CD28 -/- mice with the standard deviations depicted as y-axis error bars (E) Susceptibility  of  BALB/c CD28  '- nfice is 1L-4 depen- 
dent. CD28 +/* (CD28+) and CD28-"  (CD28-) mice were infected with L. major. Designated groups of animals were treated with 5 mg anti-IL-4 on 
day 0. Disease progression is depicted as mean lesion size for each group with the standard deviations as },-axis error bars. Results are representative of two 
experiments in which a total of six out of six BALB/c C1)28 -/- mice were treated and cured with anti-IL-4. 
CD28-deficient Mice from  the BALB/c Background  Are Sus- 
ceptible to L.  major Infection and Mount Normal IL-4--dependent 
Th2 Responses.  BALB/c CD28 +/+, CD28 +/-, and CD28  /- 
mice were  infected  with  L.  major as  described  above.  Dis- 
ease  course  was  assessed by measurement  of footpad  lesion 
size  and  quantitative  parasite  cultures.  BALB/c  CD28 -/ 
mice had progressive dissemination  that was comparable  to 
littermate  CD28-positive  controls.  Both  lesion size  (Fig.  3 
A)  and  parasite  burden  (data  not  shown)  were  similar  to 
control mice on the BALB background,  regardless  of CD28 
expression status. 
Analysis  of cytokine  production  was  performed  by  re- 
stinmlating  popliteal  lymph  node  cells  from  infected  ani- 
mals with soluble  Leishmania antigens.  Cells from BALB/c 
CD28 -/-  mice produced  less  IL-4  than  cells from  CD28- 
positive  controls  at  48  h,  but  also  produced  low  levels  of 
IFN-'/  compared  to  genetically  resistant  mice  (Fig.  3  /3). 
The  apparent  diminution  in  the  strength  of the  Th2  re- 
sponse,  however, was  only evident in the in vitro restimu- 
lation  assays.  Direct  ex  vivo  analysis  of  draining  lymph 
node  cells by  quantitative  PCP,  revealed  normal  amounts 
of IL-4  transcripts  in  BALB/c  CD28 -/  mice  (Fig.  3  C). 
ELISPOT  assays performed directly on lymph node cells of 
infected  animals  without  the  use  of antigen  restimulation 
also  revealed comparable  levels of IL-4 protein  production 
(Fig.  3  D).  While  the  ELISPOT  done  immediately  upon 
isolation showed  an  equivalent number  of IL-4-producing 
cells, a second ELISPOT  done  after 2  d  of restimulation  in 
vitro demonstrated  a  difference between  the CD28 -/  and 
wild-wpe animals  (Fig.  3  D)  similar to the  results  obtained 
from restimulation assays  (Fig. 3/3).  These data suggest that 
signals that  allow for efficient CD28-independent  Th2  de- 
velopment  in  vivo cannot  always  be  fully recapitulated  in 
vitro. 
To  formally  establish  that  susceptibility  of  BALB/c 
CD28 -/-  mice  is  caused  by  IL-4-mediated  Th2  responses 
and  not the  result  of an  imnmnodeficiency  that  weakened 
their  Thl  responses,  mice  were  treated  with  a  single  dose 
of  anti-IL-4  mAb  at  the  time  of  infection.  Anti-IL-4- 
treated  BALB/c  CD28  /-  mice  controlled  infection  corn- 
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Figure 4.  Genetic background can alter requirements for costimulation 
in Th2 development. TCR-wansgenic splenocytes from B10.D2 (C57BL) 
or BALB/c  (BALB) /nice were stimulated in vitro with  OVA peptide 
with or without (-) the addition of CTLA41g. Designated wells received 
rIL-4 (10,000 U/ml) to induce Th2  maturation. After 5 d, viable cells 
were washed and restimulated with fresh irradiated splenocytes and pep- 
tide. Supernatants were assayed for IL-4 after 48 h by ELISA. Bars depict 
the mean of triplicate wells with the standard deviation expressed as y-axis 
error  bars. 
parably to treated wild-type BALB/c mice (Fig. 3 E) and to 
genetically resistant  control  animals  (data not  shown).  We 
conclude that CD28-deficient animals can, under some cir- 
cumstances, mount fully normal Th2 responses in vivo. 
Th2 Responses can be Induced in BALB/c-transgenic  T  Cells 
in the Absence of Costimulation.  Because  of  the  unexpected 
finding  of  intact  Th2  responses  in  Leishmania-infected 
BALB/c CD28 -/- mice, we examined alternative signals  that 
promote Th2  differentiafon.  Using naive transgenic  T  cells, 
we assessed the  effect of genetic  background  and  cytokine 
environment  on  Th2  development when  T  cell activation 
was initiated  without  costimulation.  D011.10  TC1K-trans- 
genic mice were bred onto either the H-2  d congenic BALB/c 
or B10.D2  (C57BL)  backgrounds.  In these  assays,  T  cells 
undergo primary activation in the presence of experimental 
variables  such  as  rIL-4  (to  induce  Th2  maturation)  or 
CTLA4Ig  (to  block costimulation).  To  assess the  impact  of 
the initial experimental variables on early T  cell activation, 
cells are restimulated  without  cytokine  or CTLA4Ig addi- 
tion.  For cells from the  C57BL  background,  Th2  matura- 
tion  was  limited  by the  addition  of CTLA4Ig,  consistent 
with published findings (10). In contrast, BALB T  cells un- 
derwent nomlal Th2 maturation in the absence ofcostimu- 
lation  (Fig.  4).  This phenotypic  difference between  strains 
parallels and may be under the same genetic control as their 
tendency toward T  helper polarization with no cytokine or 
CTLA4Ig addition (Fig. 4 and reference 28). 
Discussion 
Since  the  initial  description  of  reciprocally  dominant 
cell-mediated  or  humoral  immune  responses  to  repeated 
injections  of flagellin  (29), it has become increasingly dear 
that  Th  responses  move  toward  polarized  maturational 
states.  Many  factors,  including  the  type  of APC,  form  of 
antigen,  route  of immunization,  genetic  background  (28, 
30),  and,  perhaps  most  notably,  the  type  of  cytokines 
present  during  activation,  can influence  biased  differentia- 
tion (reviewed in reference 31).  In the original study of re- 
petitive immunization  (29),  and in more recent studies with 
transgenic T  cells (32, 33), antigen dose was shown to par- 
ticipate in the regulation  of Th lineage  commitment.  Sev- 
eral  recent  models  of T  cell activation have proposed  that 
the strength  of signal encompassing both antigen  dose and 
quantity ofcostimulation leads to more Th2-1ike (high stim- 
ulation)  or Thl-like  (low stimulation)  outcomes (34, 35). 
Whether  there  is  a  requirement  for CD28-B7  interac- 
tion in Th subset maturation and commitment is still char- 
acterized  by significant  controversy.  Early work  on  T  cell 
clones suggested that costimulation was selectively required 
for Thl  cells. The absence of costimulation resulted in an- 
ergy of Thl  clones  (2)  and induced  Th0 clones to become 
Th2-1ike (20). By contrast,  it has recently been shown that 
costimulation  may selectively activate Th2  cells.  CD28  li- 
gation makes Th2  clones  more responsive to IL-4 (9)  and 
can be a sufficient second signal to drive Th2 development, 
even in  the  absence  of IL-4  (17,  18).  Similar  controversy 
surrounds  data  from  in  vivo  model  systems.  Although  in 
vivo blockade of B7-mediated  costimulation has prevented 
diverse  conditions  from xenograft  (3)  and  allograft  (4)  re- 
jection  to murine autoimmune  diabetes  (5),  demyelination 
(6),  and  lupus  (7),  the  regulatory  mechanisms  underlying 
these  effects  are  still  poorly  understood.  Treatment  with 
CTLA41g caused diminution  of Thl  response with sparing 
of Th2  responses in allograft transplantation  (15), but tran- 
sient  blockade  effectively  abrogated  Th2  responses  while 
sparing Thl  function in response to an intestinal nematode 
(16) and L. major (13). 
The current  study sought to determine  the requirement 
for CD28  in the generation  and maintenance  of biased Th 
responses using several well-characterized  models of CD4 + 
T  cell  maturation.  Previous  studies  have  shown  that  in 
vitro  priming  of  transgenic  T  cells  in  the  presence  of 
CTLA4Ig effectively diminished  the  ability to prime both 
Thl  and Th2  responses  (10).  In addition,  in vitro priming 
of CD28-deficient  transgenic  T  cells  can  initiate  but  not 
sustain primary proliferative responses  (11).  In vivo immu- 
nization in the presence of CTLA4Ig has led to inefficient 
clonal expansion  (36)  and effector function  (14).  Together, 
these and other results predicted that the absence of CD28 
might lead to global or selective limitations in the ability to 
generate  normal  Th  responses.  The  data  presented  here, 
however,  provide  the  first in  vivo  evidence  that  CD28  is 
not an absolute requirement to generate strong Thl  or Th2 
responses. 
In  genetically  resistant  C57BL/6  mice  lacking  CD28, 
there was no impairment in the ability to generate  IFN-~- 
secreting Thl-type  cells capable of controlling  leishmania- 
sis.  This  was  surprising  based  on  the  immunosuppressive 
capacity of CTLA4Ig in vivo (3, 4)  and given the data that 
Thl  clones  (2)  and  lines  (12)  are more  dependent  on  co- 
stimulation.  Efficient  class  lI-restricted  IFN-~/ production 
could  be  generated  in  response  to  both  a  model  antigen 
and a replicating pathogen. Both at the level ofeffector cy- 
tokine production  and  Th cell expansion  (Brown,  D.,  un- 
807  Brown et al. published results),  Thl responses  proceeded normally. This 
was not unique to the C57BL/6 genetic background, since 
BALB/c mice infected with L. major and given neutralizing 
anti-IL-4 antibodies also demonstrated normal healing re- 
sponses. 
The generation of Th2 responses in CD28-deficient mice 
is perplexing: the finding that early  CTLA4Ig administra- 
tion can prevent Th2 development in response to L.  major 
(13),  together with  the  findings  that  CD28  -/-  mice have 
reduced basal  levels  of IgG1,  increased  IgG2a and  ineffi- 
cient B cell help (8) might have led to a prediction that co- 
stimulation is required for maturation of Th2 responses.  In 
the present study, CD28-deficient mice had decreased IL-4 
production in restimulation assays after  antigen priming or 
L.  major  infection. BALB/c CD28  /- mice, however, gen- 
erated  sufficient  IL-4 to  mediate  susceptibility  as  demon- 
strated by the readily-induced resistance of anti-IL-4-treated 
mice.  Direct measurements of IL-4 gene transcription and 
protein-producing cells from BALB/c CD28 -/- mice actu- 
ally indicate  that  their  Th2  responses  against  L.  major are 
fully  intact in vivo. The apparent deficiency of IL-4 from 
in vitro assays may be caused by physical disruption of the 
cognate architecture required to compensate CD28-medi- 
ated signals in vivo, the inability to deliver important solu- 
ble factors in  the  appropriate  paracrine fashion,  or the in- 
ability  of CD28-deficient cells to survive (37) or proliferate 
normally despite  normal cytokine production. These find- 
ings raise the possibility  that many of the biologic proper- 
ties  observed after  in  vitro  manipulation  of costinmlation 
may have limited predictive value for inmmne responses  in 
vivo. 
Our data illustrates  that genetic factors can influence the 
need for costimulation. Although there was a general trend 
toward preserved Thl  and impaired Th2 development in 
CD28-'- mice, variation in genetic background may con- 
tribute  to  phenotype commitment as  much as  costimula- 
tion. In the presence of CTLA4Ig, C57BL transgenic  T cells 
could not be induced to make IL-4 even with the addition 
of rlL-4 in the primary cultures, consistent with reports us- 
ing  other  TC1K-transgenic  mice  on  the  C57BL  (B10.A) 
background (10). in contrast,  BALB/c T cells incubated with 
rlL-4 during primary activation were able to generate IL-4- 
producing  effectors  despite  the  presence  of  CTLA41g. 
There was also a background contribution to IL-4 produc- 
tion in response to KLH immunization. BALB/c mice pro- 
duced 10-fold higher IL-4 than C57BL/6 mice, consistent 
with reports of others (38). The BALB/c genetic predispo- 
sition  resulted  in  comparable  levels  of  IL-4  between 
BALB/c CD28  "- and C57BL/6 CD28 +/+ mice. It is un- 
likely,  however, that genetic polymorphism is the sole rea- 
son for preserved Th2 responses  to L. major challenge, since 
anti-IFN-3, treatment of C57BL/6 CD28  -/- mice also re- 
sulted  in increased IL-4 mlKNA (Brown, D.,  unpublished 
results).  In addition,  C57BL/6 CD28  -/-  mice are  able  to 
mount normal Th2 responses  after challenge with an intes- 
tinal helminth (Gause,  W., personal communication). 
BALB/c CD28 -/  mice were  able  to  generate  a  func- 
tional Th2 response to L.  major despite  decreased IL-4 pro- 
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duction  after  KLH  immunization.  The  reduced  restinm- 
lation  of  IL-4  seen  after  KLH  immunization  may  not 
represent  generation  of KLH-reactive  Th2  cells in  vivo, 
since  a marked discrepancy was seen between the in vitro 
restimulation  assays and  the  ex  vivo analyses  of BALB/c 
CD28 -/-  mice infected with L.  major. Assuming that  the 
impaired Th2 response of CD28  -/-  mice was indeed rep- 
resentative  of the  generation  of KLH-reactive  IL-4-pro- 
ducing ceils in vivo, other differences  between  KLH im- 
munization and Leishmania infection could account for the 
discrepancy.  Features  of the  microbial  inmmnogen  may 
obviate the need for costinmlation. The replicating nature 
of the organism may increase  the effective dose of antigen 
that could compensate the absence of costinmlation. Stud- 
ies in CTLA4Ig transgenic mice show that repeated immu- 
nization with KLH overcame a deficiency in IL-4 produc- 
tion  seen  after  a  single  imnmnization  (39).  In  addition, 
unique second signals induced by the microbe may be im- 
portant in influencing the strength and type of inmmne re- 
sponse generated. An early burst in IL-4 and IL-2 transcrip- 
tion is induced by L.  major shortly after infection (40),  and 
these  responses  are  entirely  preserved  in  CD28-deficient 
mice (Brown, D., unpublished results). 
An intact  Th2 response  in  BALB/c CD28  -/-  mice in- 
fected with  L.  major infection was  surprising given that  a 
single  dose of CTLA4Ig can evoke a curative Thl-type re- 
sponse  in  infected  wild-type  BALB/c  mice  (13).  One 
potential  explanation  for this  discrepancy is  that  develop- 
mental compensatory mechanisms have endowed CD28-" 
cells with the capacity to be activated in a manner not pos- 
sible in CD28-bearing cells. Compensation could be mani- 
fest as overproduction of soluble factor(s)  or overexpression 
of surface  molecule(s).  The  current  in  vitro  finding  that 
rlL-4 could correct impaired Th2 differentiation caused by 
CTLA4Ig might  predict  that  a  compensatory increase  in 
autocrine IL-4 production in vivo could overcome the ge- 
netic  absence  of costimulation.  Even  without  invoking 
compensatory  abnormalities,  there  are  significant  differ- 
ences  between  the  infection  of BALB/c  CD28  -/-  mice 
compared to the treatment of infected BALB/c mice with 
CTLA4Ig. The transient  nature  of blockade using CTLA4Ig 
may allow selective  outgrowth of Thl  ceils similar to other 
curative  interventions  in  BALB/c mice  that  are  based  on 
transient  reduction  in  CD4  +  T  cell  responses  (23).  Sus- 
tained  absence  of costimulation in  CD28  /-  mice  could 
favor genetically or microbially driven  outgrowth of Th2 
responses  if maintenance  of Th2  responses  is  less CI)28- 
dependent than maintenance of Thl  responses  (2,  12,  20). 
This  model would be  consistent with  the finding that  ei- 
ther sustained  or delayed blockade with CTLA4Ig was far 
less efficacious than early treatment in L. major-iufected mice 
(13).  CD28-deficient  mice  also  differ  from  CTLA4Ig- 
treated wild-type mice in the extent of blockade. The ad- 
ditional  loss of CTLA4-mediated signals  in  treated  mice 
may have distinct effects on Th development compared to 
the  absence of CD28  alone.  Treatment of CD28  J-  mice 
with CTLA4Ig, however, failed to abrogate Th2 responses 
(Brown, D., unpublished results),  consistent with data  that 
Helper 2 Responses m CD28-deficient Mice T  cell activation in CD28-deficient mice is not B7-depen- 
dent (41). 
The maturation of Th precursors into biased Thl  or Th2 
subsets is affected by numerous factors. The present results 
demonstrate that CD28  is not an absolute requirement for 
generating  either  of the  polarized subsets.  BALB/c-trans- 
genic  T  cells  activated  in  the  presence  of rlL-4  can  be 
primed to become  Th2  cells in the  absence of costimula- 
tion  through  CD28.  Conversely,  studies  with  human  T 
ceils have demonstrated an ability to generate Th2 cells de- 
spite  neutralization  of IL-4  if CD28-mediated  costimula- 
tion  was provided  (17,  18).  Together,  these findings sup- 
port a complex model of Th maturation in which there are 
distinct  sufficient  signals  for  Th2  development  rendering 
no  signal an absolute necessity depending on the presence 
of the other determinants. Thl  clones can also be coopera- 
tively costimulated by B7 and rlL-12 (42). This finding, to- 
gether with recent descriptions of novel Thl  costimulatory 
molecules  (43)  and  Thl-inducing cytokines  (44),  suggests 
similar redundancy in the Thl pathways. Models of Th cell 
differentiation will need  to  account for the  complexity of 
factors that influence polarized Th responses. 
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